Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “intercept”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 361 records · Page 20Linked to original sources
PubMed1981

A new interceptive treatment of cases with missing maxillary lateral incisors. A preliminary report.

A new approach to achieve space closure in cases with missing maxillary lateral incisors is presented. The maxillary first primary molar is extracted just before the eruption of the first permanent molar to make mesial drifting into distal occlusion between the permanent molars possible, which is requested to compensate for the missing incisor. Prerequisites for the treatment and preliminary results are demonstrated.

Anodontia↗
PubMed1978

[Preventive and interceptive orthodontics].

The Authors are stating the importance of prevention in Dentistry so as to stop anomalies of jaws and teeth of from forming. They mean therapy all those measures to use with simple means, both surgical and Orthopedic, and them detting its limits and possibilities. A classification is being proposed which will divide them into prophylaxis, prevention, interseption, and early therapy.

Deglutition Disorders↗
PubMed1995

Interceptive approach to tooth eruption abnormalities: 10 year follow-up of a case.

A child affected by lack of eruption of the upper right primary cuspid from the presence of a compound odontoma was followed from 3 to 13 years of age. The early removal of the obstacle to eruption and the correct control of the case evolution allowed for a satisfactory alignment of the permanent teeth by means of minimal therapeutical intervention.

Child, Preschool↗
PubMed2026

Serum Proteomic Signatures of Rheumatoid Arthritis Risk and Response: Analysis of a Rheumatoid Arthritis Interception Trial.

OBJECTIVE: Our study objective was to identify serum protein signatures associated with progression to rheumatoid arthritis (RA) and response to abatacept in at-risk individuals. METHODS: A total of 440 serum samples from 118 APIPPRA (Arthritis Prevention In the Preclinical Phase of RA with Abatacept) study participants were selected from baseline to RA onset for 46 progressors of RA or to study end for 72 participants who did not develop RA. Samples were analyzed using the SomaScan 7k assay platform. Differential expression analysis was assessed by progression to RA (three pre-RA time intervals to RA, progressors of RA vs nonprogressors, baseline to RA), and by treatment allocation (abatacept vs placebo). Risk and response signatures were identified in the full 7k panel and two prespecified subpanels defined as Inflammatory Mediators and Adaptive Immune Cell panel. RESULTS: We observed significant changes in 80 proteins (68 down-regulated and 12 up-regulated) occurring between RA onset and 6 to 24 months before developing disease. Progression to RA was associated with increased levels of acute-phase reactants SAA1 and SAA2 and reductions in CTLA4, when compared to nonprogressors at the end of treatment. Two up-regulated proteins (CTLA4 and CD86) and seven down-regulated proteins (CXCL13, FCRL4, FCER2, CCL21, LTA|LTB, FDCSP, and IL22RA2) were observed in participants receiving abatacept compared to placebo regardless of RA outcome. CONCLUSION: Protein signatures dominated by acute-phase proteins define progression to RA, whereas changes associated with abatacept therapy highlight potential mechanisms of treatment response. Such signatures provide a better understanding of the immune landscape of the at-risk phase, opening up the possibility of new treatment modalities for RA prevention.

Adult↗
PubMed2003

Computational assessment of the electronic structure of 1-azacyclohexa-2,3,5-triene (3 delta 2-1H-pyridine) and its benzo derivative (3 delta 2-1H-quinoline) as well as generation and interception of 1-methyl-3 delta 2-1H-quinoline.

Treatment of a solution of 3-bromo-1-methyl-1,2-dihydroquinoline (9) and [18]crown-6 in furan or styrene with KOtBu followed by hydrolysis afforded a mixture of 1-methyl-1,2-dihydroquinoline (10) and 1-methyl-2-quinolone (11). If the reaction was performed in [D(8)]THF and the mixture was immediately analysed by NMR spectroscopy, 2-tert-butoxy-1-methyl-1,2-dihydroquinoline (17) was shown to be the precursor of 10 and 11. The structure of 17 is evidence for the title cycloallene 7, which arises from 9 by beta elimination of hydrogen bromide and is trapped by KOtBu to give 17 so fast that cycloadditions of 7 with furan or styrene cannot compete. Since this reactivity is unusual compared to the large majority of the known six-membered cyclic allenes, we performed quantum-chemical calculations on 8, which is the parent compound of 7, and the corresponding isopyridine 6 to assess the electronic nature of these species. The ground state of 6 was no longer an allene (6 a) but the zwitterion 6 b. In the case of 8, the allene structure 8 a is more stable than the zwitterionic form 8 b by only approximately 1 kcal mol(-1). These results suggest a high reactivity of 6 and 8 towards nucleophiles and explains the behaviour of 7. In addition to the ground states, the low-lying excited states of 6 and 8 were considered, which are represented by the diradicals 6 c and 8 c and, as singlets, lie above 6 b and 8 a by 19.1-24.8 and 14.4-17.7 kcal mol(-1), respectively.

Journal Article↗
PubMed1989

Interception of the development of self tolerance in fetal lambs.

Investigation of the nature of immunological self tolerance has usually relied upon experimental protocols in which the tolerant state is interrupted in mature animals with the production of autoimmune disease. While such research has improved the understanding of those processes operative in overt autoimmunity, it has not been informative in relation to events associated with the establishment of self tolerance. Any description of this state which is to be based on observation will necessitate the use of experimental systems that permit observation of animals during the development of self tolerance. The present experiment entailed intervention approximately one third of the way through the gestation period of fetal lambs. An earlier experiment had established that 54-day fetal lambs would accept allografts of adult skin. This indicated that the capacity to discriminate between self and non-self had not been acquired at that age. Fetuses at this stage of gestation were submitted to either partial or total removal of the thyroid gland. The excised tissue was then implanted in nude mice for periods of 5 to 9 weeks. It was subsequently replaced subcutaneously, either in the original donor or in another fetus at a comparable stage of gestation. At postmortem examination, several weeks later, self implants in lambs from which the thyroid gland had been completely removed displayed autoimmune thyroiditis of varying degrees of severity. However, self implants in partially thyroidectomized animals were uniformly free from autoimmune manifestations. This implied that these reactions had not been directed against contaminating murine tissues in the implants replaced in completely thyroidectomized lambs. All allogeneic implants were subject to vey heavy lymphocytic infiltration, usually with accompanying necrosis consistent with allograft rejection. This was taken as an indication that hypothyroid fetal lambs had become immunocompetent by the time of thyroid reimplantation. Spontaneous immunological reactivity against reimplanted self thyroid tissue by thyroidectomized lambs was interpreted as a failure to acquire the capacity for self recognition as a result of antigen deprivation.

Animals↗